Complex regional pain syndrome is a chronic condition arising mainly after tissue injury and involves both inflammatory and neurogenic factors. Use of angiotensin-converting-enzyme inhibitors has been associated with an increased risk of developing the chronic pain condition, which suggests possible roles for substance P and bradykinin in the underlying pathogenic process.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
de Mos, M., Huygen, F. J., Stricker, B. H., Dieleman, J. P. & Sturkenboom, M. C. The association between ACE inhibitors and the complex regional pain syndrome: suggestions for a neuro-inflammatory pathogenesis of CRPS. Pain 142, 218–224 (2009).
Jänig, W. & Baron, R. Complex regional pain syndrome is a disease of the central nervous system. Clin. Auton. Res. 12, 150–164 (2002).
Leeb-Lundberg, L. M., Marceau, F., Müller-Esterl, W., Pettibone, D. J. & Zuraw, B. L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol. Rev. 57, 27–77 (2005).
Kopp, U. C., Cicha, M. Z. & Smith, L. A. Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP. Am. J. Physiol. 285, 472–483 (2003).
Parpura, V. et al. Glutamate-mediated astrocyte-neuron signalling. Nature 369, 744–747 (1994).
Fusayasu, E., Kowa, H., Takeshima, T., Nakaso K. & Nakashima, K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128, 209–214 (2007).
Suzuki, R., Morcuende, S., Webber, M., Hunt, S. P. & Dickenson, A. H. Superficial NK1-expressing neurons control spinal excitability through activation of descending pathways. Nat. Neurosci. 5, 1319–1326 (2002).
Budai, D., Khasabov, S. G., Mantyh, P. W. & Simone, D. A. NK-1 receptors modulate the excitability of ON cells in the rostral ventromedial medulla. J. Neurophysiol. 97, 1388–1395 (2007).
McMahon, S. B., Cafferty, W. B. & Marchand, F. Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444–462 (2005).
Hay, J. L. et al. Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients. J. Pain 10, 316–322 (2009).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Borsook, D., Sava, S. Do ACE inhibitors exacerbate complex regional pain syndrome?. Nat Rev Neurol 5, 306–308 (2009). https://doi.org/10.1038/nrneurol.2009.73
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.73
This article is cited by
-
Bradykinin Receptors Play a Critical Role in the Chronic Post-ischaemia Pain Model
Cellular and Molecular Neurobiology (2021)
-
Komplexes regionales Schmerzsyndrom nach distaler Radiusfraktur
Der Unfallchirurg (2016)